[1] | Guoguo ZHI, Jie MU, Bingjie SHAO, Dong WANG. Mechanism of action of lipotoxicity in nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2023, 39(7): 1681-1686. doi: 10.3969/j.issn.1001-5256.2023.07.024 |
[2] | Enrui XIA, Gege TIAN, Suyan ZHANG, Shunzhen ZHANG. Effect of Quzhi Ruangan prescription on the farnesoid X receptor-fibroblast growth factor 19 pathway in rats with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2022, 38(5): 1069-1074. doi: 10.3969/j.issn.1001-5256.2022.05.018 |
[3] | Song QingLian, Tan YuE, Liu JingJing, Yuan BeiBei, Li Min, He LiQin, Dai GuangRong. Establishment of a rat model of nonalcoholic steatohepatitis and histopathological changes of the pancreas and the kidney[J]. Journal of Clinical Hepatology, 2020, 36(1): 140-144. doi: 10.3969/j.issn.1001-5256.2020.01.031 |
[4] | Zhang LiHui, Zhang JianBo, Zhao WenXia. Effect of Huatan Qushi Huoxue prescription on the key proteins of the ADPN/PI3K/Akt signaling pathway in rats with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 835-839. doi: 10.3969/j.issn.1001-5256.2020.04.025 |
[5] | Chen Jun, Li LiangPing, Fu WanZhi. Value of microparticles in the diagnosis of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2019, 35(9): 2026-2031. doi: 10.3969/j.issn.1001-5256.2019.09.028 |
[6] | Guo Yan, Huang Li, Yang GuoChao, Liu Shan, Du LinNa, Wang MinJuan. Association between nonalcoholic fatty liver disease and dietary inflammation index and its practical significance[J]. Journal of Clinical Hepatology, 2019, 35(10): 2324-2326. doi: 10.3969/j.issn.1001-5256.2019.10.042 |
[7] | Zhou QingLi, Xu ZhenYuan, Zhang SuYan, Shi AnHua, Zhang ShunZhen. The role of the NOD-like receptor family, pyrin domain-containing protein 3 inflammasome in nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2019, 35(6): 1380-1383. doi: 10.3969/j.issn.1001-5256.2019.06.045 |
[8] | Zhang ChaoXian, Guo LiKe, Zhang LiLi, Li GuangYan, Chang TingMin. Interaction between Helicobacter pylori infection and polymorphisms of PPAR-γ2 gene Pro12Ala and GPx-1 gene Pro198Leu and its association with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2019, 35(7): 1551-1559. doi: 10.3969/j.issn.1001-5256.2019.07.026 |
[9] | Jiang Yu, Hu JuLong, Ma JiaLi, Li Ping, Zhou YuLing, Liang XiuXia, Ai ZhengLin, Yao ShuKun. Antioxidant effect of berberine in a rat model of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2018, 34(6): 1273-1276. doi: 10.3969/j.issn.1001-5256.2018.06.028 |
[10] | Hu MengQi, Xu YouQing, Zhang Tao, Xu HongTuan. Research advances in noninvasive diagnostic methods for nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2017, 33(12): 2288-2291. doi: 10.3969/j.issn.1001-5256.2017.12.006 |
[11] | Zhao WenXia, Yan Le, Shao MingYi, Zhang LiHui. Effect of Huatan Qushi Huoxue prescription on the ADPN/AMPK/ACC signaling pathway in rats with nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2017, 33(5): 932-936. doi: 10.3969/j.issn.1001-5256.2017.05.029 |
[12] | Zhu JuanJuan, Cheng MingLiang, Zhao XueKe. Role of liver immunological inflammation in development and progression of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2016, 32(3): 570-573. doi: 10.3969/j.issn.1001-5256.2016.03.038 |
[13] | Ding Jie, Wang Liang, Li Juan, Kong Yin, Zhao Rui, He JingJing, Li GuangMing, Wang JuanXia, Zhang LingYi. Changes in serum asymmetric dimethylarginine levels in progression of liver inflammation in an experimental rat model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2016, 32(1): 148-151. doi: 10.3969/j.issn.1001-5256.2016.01.029 |
[14] | Xin Xuan, Yan HongZhu, Li WeiQing, Yu HongYu. Studies on PPAR α and γ participating in progression of liver fibrosis by regulating ACSL1[J]. Journal of Clinical Hepatology, 2014, 30(7): 700-702. doi: 10.3969/j.issn.1001-5256.2014.07.034 |
[15] | Xin Xuan, Yan HongZhu, Li WeiQing, Yu HongYu. Studies on PPAR α and γ participating in progression of liver fibrosis by regulating ACSL1[J]. Journal of Clinical Hepatology, 2014, 30(8): 833-835. doi: 10.3969/j.issn.1001-5256.2014.08.038 |
[16] | Cheng Rui, Cai XinRan, Zhou HaoHui, Han ShengHua, Zhu JinHai, Chen HuiXing, Chen YanLing. Omega-3 polyunsaturated fatty acids inhibit inflammation during the early stage of acute pancreatitis[J]. Journal of Clinical Hepatology, 2012, 28(8): 598-602. |
[17] | Chen Jie, Ceng LingLan, Wang Hua, Liu Chao. Effects of asiatic acid on the expression of mRNA of smad7 and PPARγ in HSC-T6 in vitro[J]. Journal of Clinical Hepatology, 2011, 27(3): 251-253+264. |
[18] | Huang Ning, Wu WanChun. The effect of low iron loads on Nonalcoholic Steatohepatitis in rats[J]. Journal of Clinical Hepatology, 2009, 25(6): 427-430. |
[19] | Wang HuiChao, Ye HongJun, Wei ShiLiang, Liu XiaoYi, Wan HuiJuan, Du YiPing. Therapeutic effects of compound glycyrrhizin liposome on rats with nonalcoholic steatohepatitis.[J]. Journal of Clinical Hepatology, 2008, 24(3): 199-201. |
[20] | Xu Hui, Wen QinSheng, Wang XuXia, Zhang YaFei, Li Jun, Gu BingQuan. The effect of cimetidine on the blood sugar, serum insulin and other indexes in NASH rats[J]. Journal of Clinical Hepatology, 2007, 23(2): 112-114. |